Table 1 Baseline characteristics and health markers among study groups (n = 1306)
From: Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers
Healthy | Alzheimer's disease | Vascular dementia | Deceased | |
|---|---|---|---|---|
Number | 596 (45.6%) | 149 (11.4%) | 96 (7.3%) | 465 (35.7%) |
Gender, male | 249 (41.8%) | 34 (22.8%) | 42 (43.7%) | 246 (37.1%) |
Age at the event, years | 76 (10) * | 82 (9) | 83 (7) | 83 (13) |
Age at study entry, years | 55 (11) | 71 (11) | 71 (7) | 75 (15) |
rLTL | 0.026 (0.16) | –0.045 (0.17) | –0.046 (0.18) | –0.055 (0.14) |
APOE ε4-carriers | 152 (25.5%) | 78 (52.3%) | 31 (32.3%) | 102 (15.4%) |
Serum cholesterol, mg/dL | 250.96 (57.9) | 270.27 (54.1) | 262.55 (54.1) | 254.83 (65.6) |
Pulse pressure, mmHg | 50 (20) | 65 (25) | 70 (20) | 65 (25) |
Plasma glucose, mg/dL | 93.69 (16.2) | 93.69 (14.4) | 97.29 (21.6) | 97.29 (18.1) |
Sedimentation rate, mm/h | 9 (8) | 14 (15) | 12.5 (11) | 14 (12) |
Lymphocyte proportion | 0.316 (0.09) | 0.306 (0.09) | 0.277 (0.10) | 0.290 (0.10) |